logo
logo

Pharmeasy Closes $350 Million In Pre-Ipo Round, Valuation Jumps To $5.6 Billion

Oct 18, 2021over 3 years ago

Amount Raised

$350 Million

Description

Online pharmacy PharmEasy has closed a funding round worth nearly $350 million ahead of filing its draft red herring prospectus (DRHP) before an Initial Public Offering (IPO), according to regulatory documents sourced by ET and people briefed on the matter.

Company Information

Company

Pharm Easy

About

PharmEasy was valued at $4 billion after it acquired diagnostics chain Thyrocare for over $600 million in June.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech